ghk cu peptide clinical evidence Excellent article on both topical and systemic peptides, just missing melanotan information! Very well written by Macrene Alexiades, MD, PhD @drmacrene in @gohealio newsletter. I'm often asked about copper GHK-Cu peptide. Here GHK-Cu Peptide: Clinical Evidence &

The NF-B Connection NF-B (nuclear factor kappa-light-chain-enhancer of activated B cells) is the master regulator of inflammatory gene transcription

COMIRNATY (COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19 Vaccine intended for individuals 12 years of age and older should not be used for individuals 6 months through 11 years of age because of the potential for vaccine administration errors, including dosing errors

(It probably also doesnt help that peptides are commonly injected, likely causing many people to associate them with steroids, although GLP-1s have done a lot to move past that taboo.) But a potential recategorization of these peptides could change all of that

The submission window is narrow, usually 24-72 hours after an emergency admission

10.1093/molehr/gax019 105

Its ability to penetrate the BBB, its metabolic stability, and its significant efficacy in restoring cognitive and motor functions in animal models of AD and PD, likely through modulating the HGF/c-Met system, position it as a highly promising therapeutic candidate for these debilitating neurodegenerative diseases [2]